Pulmonary Hypertension - From Bench Research to Clinical Challenges 2011
DOI: 10.5772/26198
|View full text |Cite
|
Sign up to set email alerts
|

Pulmonary Hypertension: Endothelial Cell Function

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0
1

Year Published

2014
2014
2020
2020

Publication Types

Select...
4
1

Relationship

3
2

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 109 publications
0
5
0
1
Order By: Relevance
“…BMPR2 gene therapy fails to inhibit MCT-induced PH; however, administration of GDF2 (growth differentiation factor 2, also known as BMP9) was shown to have preventive and reversal effect on experimental PH [9,10]. BMPR2 is predominantly expressed in endothelial cells and a part of it co-localizes with CAV1 [11], and the loss of BMPR2 increases the susceptibility to DNA damage [12]. The increased expression of SMURF1 (SMAD specific E3 ubiquitin protein ligase 1) that induces lysosomal and proteosomal degradation of BMPR2 has been shown to occur in patients with PAH, as well as in hypoxia and MCT-induced PH.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…BMPR2 gene therapy fails to inhibit MCT-induced PH; however, administration of GDF2 (growth differentiation factor 2, also known as BMP9) was shown to have preventive and reversal effect on experimental PH [9,10]. BMPR2 is predominantly expressed in endothelial cells and a part of it co-localizes with CAV1 [11], and the loss of BMPR2 increases the susceptibility to DNA damage [12]. The increased expression of SMURF1 (SMAD specific E3 ubiquitin protein ligase 1) that induces lysosomal and proteosomal degradation of BMPR2 has been shown to occur in patients with PAH, as well as in hypoxia and MCT-induced PH.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, Cav1 knockout mice develop PH which can be reversed by reconstituting endothelial Cav1 [16,17]. Extensive loss of endothelial CAV1 accompanied by enhanced expression of CAV1 in vascular smooth muscle cells (VSMC) has been reported in IPAH, HPAH, in PAH associated with congenital heart defect and drug toxicity [11,[18][19][20] and in infants with bronchopulmonary dysplasia and evidence of inflammation [19]. Furthermore, pulmonary artery smooth muscle cells isolated from patients with PH revealed enhanced expression of CAV1, increased capacitative Ca 2+ entry and increased DNA synthesis which could be blocked by…”
Section: Introductionmentioning
confidence: 99%
“…In susceptible individuals, augmentation of pulmonary arterial pressure results in PH and ET-1 secretion above the upper physiological limits. ET-1 migrates to muscle cells, where it enhances Ca 2+ -calmodulin way and protein kinases; muscle contraction ensues and the remodeling process takes place due to a complex molecular framework (16,17). Although the mechanism of action of ET-1 in the pulmonary Para declarar diferencias estadísticas, el nivel de significancia tuvo que ser p<0.01.…”
Section: Discussionmentioning
confidence: 99%
“…When this compensatory mechanism is sustained as to increase pulmonary arterial blood flow and overpass physiological levels, PH occurs (4,5). Also, nitric oxide synthase sequester can develop, thus inhibiting vasodilatation due to decrease in nitric oxide (6). This endothelial dysfunction, vasoconstrictors predominate and vascular remodeling ensues, which entails thickening of the middle muscle and the adventitia layers in arterioles (5).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation